Condition
Tenecteplase
Total Trials
6
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
P 2 (1)
P 3 (3)
Trial Status
Not Yet Recruiting3
Recruiting2
Unknown1
Clinical Trials (6)
Showing 6 of 6 trials
NCT07357987Phase 3Recruiting
Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke
NCT07475936Not Yet Recruiting
Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke
NCT07475949Phase 3Not Yet Recruiting
Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging
NCT07168278Phase 3Not Yet Recruiting
Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT
NCT06621121Recruiting
A Real-world Study of Tenecteplase Versus Alteplase for Thrombolysis in Patients Within 4.5 H of Onset of Ischemic Stroke
NCT05580822Phase 2Unknown
Additive Effects of Intra-arterial Tenecteplase for Successful Thrombectomy Due to Acute Basilar Artery Occlusion
Showing all 6 trials